# Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension

> **NCT01410188** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kubota Vision Inc.** · enrollment: 160 (actual)

## Conditions studied

- Primary Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** OPA-6566
- **DRUG:** Placebo
- **DRUG:** Latanoprost

## Key facts

- **NCT ID:** NCT01410188
- **Lead sponsor:** Kubota Vision Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2014-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01410188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01410188, "Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01410188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*